Skip to content

Dexmedetomidine for attenuated airway reflexes and improved quality of emergence from general anesthesia in patients undergoing intravascular intervention surgery: a prospective randomized controlled study

Dexmedetomidine ameliorates quality of emergence from general anesthesia in patients undergoing intravascular intervention surgery: a dose-finding study

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000032175
Enrollment
Unknown
Registered
2020-04-22
Start date
2020-05-01
Completion date
Unknown
Last updated
2020-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intravascular intervention surgery

Interventions

Group 5:saline
Group 1:Dexmedetomidine 0.3ug/kg.h
Group 2:Dexmedetomidine 0.4ug/kg.h
Group 3:Dexmedetomidine 0.5ug/kg.h
Group 4:Dexmedetomidine 0.6ug/kg.h

Sponsors

Renmin Hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients who need general anesthesia for intravascular interventional operation and whose operation time is expected to be less than 4 hours; 2. Patients with aged >= 18 years, and ASA grade <= 3.

Exclusion criteria

Exclusion criteria: 1. Patients who are allergic to dexmedetomidine; 2. Patients with morbid obesity (BMI > 35); 3. Patients with mental system diseases (such as schizophrenia, depression, etc.) and cognitive dysfunction; patients with history of epilepsy; patients with previous history of abuse of psychotropic drugs and narcotic drugs; 4. Patients with severe injury of liver and kidney function, ALT and / or AST > 1.5 times of the upper limit of normal value and creatinine value < 30; 5. Patients who participated in clinical studies of other drugs in recent three months.

Design outcomes

Primary

MeasureTime frame
the grade of cough during extubation;

Countries

China

Contacts

Public ContactEyou Wang

Renmin Hospital of Wuhan University

844097617@qq.com+86 27-68772100

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026